c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
|
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [21] Effect of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced tau protein hyperphosphorylation
    Cao, Minghui
    Liu, Funing
    Ji, Fengtao
    Liang, Jianjun
    Liu, Ling
    Wu, Qiang
    Wang, Tinghuai
    BEHAVIOURAL BRAIN RESEARCH, 2013, 237 : 249 - 255
  • [22] Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases
    Muth, Felix
    Guenther, Marcel
    Bauer, Silke M.
    Doering, Eva
    Fischer, Sabine
    Maier, Julia
    Drueckes, Peter
    Koeppler, Juergen
    Trappe, Joerg
    Rothbauer, Ulrich
    Koch, Pierre
    Laufer, Stefan A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 443 - 456
  • [23] c-Jun N-Terminal Kinase is Upregulated in Patients With Hypospadias
    Li, Mingyong
    Qiu, Lin
    Lin, Tao
    He, Dawei
    Hua, Yi
    Yuan, Xingang
    Liu, Xing
    Wei, Guanghui
    UROLOGY, 2013, 81 (01) : 178 - 183
  • [24] c-Jun N-terminal kinase signaling in cellular senescence
    Ying Deng
    Vojtech Adam
    Eugenie Nepovimova
    Zbynek Heger
    Marian Valko
    Qinghua Wu
    Wei Wei
    Kamil Kuca
    Archives of Toxicology, 2023, 97 : 2089 - 2109
  • [25] Seven Cysteine-Deficient Mutants Depict the Interplay between Thermal and Chemical Stabilities of Individual Cysteine Residues in Mitogen-Activated Protein Kinase c-Jun N-Terminal Kinase 1
    Nakaniwa, Tetsuko
    Fukada, Harumi
    Inoue, Tatsuya
    Gouda, Masaki
    Nakai, Ryoko
    Kirii, Yasuyuki
    Adachi, Motoyasu
    Tamada, Taro
    Segawa, Shin-ichi
    Kuroki, Ryota
    Tada, Toshiji
    Kinoshita, Takayoshi
    BIOCHEMISTRY, 2012, 51 (42) : 8410 - 8421
  • [26] c-Jun N-terminal kinase signaling in cellular senescence
    Deng, Ying
    Adam, Vojtech
    Nepovimova, Eugenie
    Heger, Zbynek
    Valko, Marian
    Wu, Qinghua
    Wei, Wei
    Kuca, Kamil
    ARCHIVES OF TOXICOLOGY, 2023, 97 (08) : 2089 - 2109
  • [27] Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear Factor-κB, but not C-Jun N-terminal kinase and activated protein-1
    Gulati, AP
    Yang, YM
    Harter, D
    Mukhopadhyay, A
    Aggarwal, BA
    Benzil, DL
    Whysner, J
    Albino, AP
    Murali, R
    Jhanwar-Uniyal, M
    MOLECULAR CARCINOGENESIS, 2006, 45 (01) : 26 - 37
  • [28] Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase
    Biggi, Silvia
    Buccarello, Lucia
    Sclip, Alessandra
    Lippiello, Pellegrino
    Tonna, Noemi
    Rumio, Cristiano
    Di Marino, Daniele
    Miniaci, Maria Concetta
    Borsello, Tiziana
    NEURAL PLASTICITY, 2017, 2017
  • [29] c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage
    Michel-Monigadon, Delphine
    Bonny, Christophe
    Hirt, Lorenz
    CEREBROVASCULAR DISEASES, 2010, 29 (06) : 564 - 570
  • [30] Effects of hyperglycemic and normoglycemic cerebral ischemia on phosphorylation of C-jun NH2-terminal kinase (JNK) and P38 mitogen-activated protein kinase (MAPK)
    He, QP
    Ding, C
    Li, PA
    CELLULAR AND MOLECULAR BIOLOGY, 2003, 49 (08) : 1241 - 1247